Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 2006

Amitiza(Lubiprostone)

Medicare prescription drug cost, prescriptions and prescribers, 2024

$2.9M

Medicare cost, 2024

Medicare drug plans spent $2.9 million on Amitiza (lubiprostone) in 2024, for 6,882 prescriptions and refills filled by 2,367 patients. Spending fell 65% from 2023 to 2024. New York accounts for the most spending ($333,522, 11% of the total).

Medicare cost, 2024

$2.9M

-65.4% from 2023

Prescriptions

6,882

$422.58 per claim

Patients

2,367

2,449 prescribers

Total spending, 2024

$2.9M

$1,228.88 per patient

Questions and answers

How much does Medicare spend on Amitiza?

Medicare prescription drug plans paid $2.9M for Amitiza in 2024, for 6,882 prescriptions and refills to 2,367 patients (down 65.4% from 2023). The average cost per claim was $422.58.

Which state spends the most on Amitiza?

New York had the highest Medicare cost for Amitiza in 2024: $334K for 815 claims, followed by California ($266K).

Who prescribes Amitiza the most?

Nicole K Nichols, nurse practitioner in Saint Louis, MO, had the highest Medicare cost for Amitiza in 2024: 13 claims costing $9,088.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Amitiza was $2.9M in 2024, after a high of $279.3M in 2020.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Amitiza, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Nicole K Nichols Saint Louis, MONurse Practitioner13Under 11$9,088
Victor Lyapis Colusa, CAGeneral Practice38Under 11$9,003
Inna Gordin Brooklyn, NYInternal Medicine23Under 11$8,882
Scott Estabrook Danbury, CTGastroenterology12Under 11$7,864
Gavriel Fuzaylov Forest Hills, NYInternal Medicine19Under 11$6,917
Scott M Smukalla New York, NYGastroenterology19Under 11$6,868
Dina Sverdlov San Mateo, CAInternal Medicine24Under 11$6,854
1174732663 Internal Medicine28Under 11$6,751
Konstantin Peysin Brooklyn, NYInternal Medicine22Under 11$6,603
Grigoriy E Gurvits New York, NYGastroenterology23Under 11$6,207
Summer A Hinthorne Normal, ILNurse Practitioner12Under 11$5,440
Anabelle Ramos Rosado Belen, NMFamily Practice14Under 11$5,404
Jordan M Dunitz Minneapolis, MNPulmonary Disease13Under 11$5,281
Timothy C Kleinschmidt Duluth, MNInternal Medicine17Under 11$5,236
Jarod J Marcotte Leavenworth, KSPhysician Assistant13Under 11$5,199
Zarine Ter-Poghosyan Burbank, CAFamily Practice13Under 11$5,076
Vamsi K Kantamaneni Decatur, GAGastroenterology14Under 11$5,048
Yervand Set Agayan Glendale, CAFamily Practice13Under 11$5,039
Timothy C Dickey Columbia, TNNurse Practitioner13Under 11$5,004
Bryan A Hubl Hebron, NEFamily Practice13Under 11$4,969
Fernando T Itable Milwaukee, WIInternal Medicine13Under 11$4,941
Kathryn B Overberg Louisville, KYNurse Practitioner13Under 11$4,829
Anisaa W Romano Perry Andrews, NCFamily Practice12Under 11$4,816
Humera Ahmed Frisco, TXInternal Medicine12Under 11$4,757
Soo W Kang Buena Park, CAInternal Medicine13Under 11$4,740

Prescriber data by year

YearPrescribersClaimsPatientsCost
202214,05949,82115,665$23.1M
20235,72218,5815,732$8.4M
20242,4496,8822,367$2.9M

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Takeda PharmaceTAK logoTAK4,909$1.9M
Mallinck-Specgx1,978$1.0M

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
3
RxNorm concept IDs
616578, 617768, 794639, 794641
Application numbers
NDA021908

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube